SEXUAL DYSFUNCTION IN PATIENTS WITH IRRITABLE-BOWEL-SYNDROME AND NONULCER DYSPEPSIA

Citation
R. Fass et al., SEXUAL DYSFUNCTION IN PATIENTS WITH IRRITABLE-BOWEL-SYNDROME AND NONULCER DYSPEPSIA, Digestion, 59(1), 1998, pp. 79-85
Citations number
28
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
00122823
Volume
59
Issue
1
Year of publication
1998
Pages
79 - 85
Database
ISI
SICI code
0012-2823(1998)59:1<79:SDIPWI>2.0.ZU;2-X
Abstract
The prevalence and type of sexual dysfunction in patients with functio nal gastrointestinal (GI) disorders involving the upper (functional dy spepsia) or lower GI tract (irritable bowel syndrome) were studied in 683 patients seen at a tertiary referral center and a comparison group of 247 community volunteers. Associations between sexual dysfunction and type and severity of GI symptoms, and psychological symptoms were examined. All subjects were evaluated with a validated bowel syndrome questionnaire, which included questions about sexual function. Psychol ogical symptom severity was assessed by SCL-90R, The prevalence of sel f-reported sexual dysfunction in patients with functional GI disorders was 43.3% and did not differ by gender, age stratification or disease subtype: irritable bowel syndrome (IBS); non-ulcer dyspepsia (NUD), a nd IBS+NUD, In the comparison subjects without IBS symptoms and those with IBS symptoms but not seeking health care (IBS non-patients), the reported sexual dysfunction prevalence was significantly lower (16.1 a nd 24.4 %, respectively, p < 0.005). Decreased sexual drive was the sy mptom most commonly reported by both male (36.2%) and female (28.4%) p atients. Dyspareunia was reported by 16.4% of females and 4% of males with IBS, but was rarely observed in patients with NUD. Report of sexu al dysfunction was positively associated with perceived GI symptom sev erity, but not with psychological symptom severity. Sexual dysfunction should be incorporated into the quality-of-life assessment of patient s with functional GI disorders and addressed in future outcome studies .